Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.61 |
| ▸ | AR | P10275 | 3/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.57 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | AXL | P30530 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30274254 | 1.00 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E | |
| Trifluoroacetic Acid SCHEMBL30260083 | 0.87 | MAOB (0.53) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL8373024 | 0.78 | MAOB (0.62) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL10344116 | 0.78 | MAOB (0.62) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL24969554 | 0.77 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL15147107 | 0.77 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL9819236 | 0.77 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL8185206 | 0.77 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL69392 | 0.77 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E | |
| SCHEMBL27956971 | 0.77 | MAOB (0.61) | MAOBADORA3ARCYP19A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6096907-A | REDUCING A 7-HYDROXY-4-CHROMANONE OR DERIVATIVE WITH ZINC AND AN ACID | BASF AKTIENGESELLSCAHFT (DE) | 2000-08-01 | — | — | US | claimed |
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | Ryvu Therapeutics S.A. (PL) | 2024-12-10 | — | — | US | disclosed |
| CN-115925665-B | PDE4 inhibitor and application thereof | 中国药科大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-115925665-A | PDE4 inhibitor and application thereof | 中国药科大学 | 2023-04-07 | — | — | CN | disclosed |
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-12-22 | — | — | US | disclosed |
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2022-12-22 | — | — | US | disclosed |
| WO-2019238786-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2019-12-19 | — | — | WO | disclosed |
| US-20150141241-A1 | SEPARATING AGENT FOR OPTICAL ISOMER | National University Corporation Nagoya University a corporation | 2015-05-21 | — | — | US | disclosed |
| EP-2758366-A1 | PROCESS FOR PREPARING CHIRAL QUINONE | DSM IP Assets B.V. (NL) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013041676-A1 | PROCESS FOR PREPARING CHIRAL QUINONE | DSM IP ASSETS B.V. (NL) | 2013-03-28 | — | — | WO | disclosed |
| CN-1116292-C | Process for preparing benzodihydropyranol deriv. | BASF AG (DE) | 2003-07-30 | — | — | CN | disclosed |
| US-6096907-A | REDUCING A 7-HYDROXY-4-CHROMANONE OR DERIVATIVE WITH ZINC AND AN ACID | BASF AKTIENGESELLSCAHFT (DE) | 2000-08-01 | — | — | US | disclosed |
| US-6096907-A | REDUCING A 7-HYDROXY-4-CHROMANONE OR DERIVATIVE WITH ZINC AND AN ACID | BASF AKTIENGESELLSCAHFT (DE) | 2000-08-01 | — | — | US | disclosed |
| CN-1249306-A | Process for preparing benzodihydropyranol deriv. | BASF AG (DE) | 2000-04-05 | — | — | CN | disclosed |
| JP-2000095776-A | PRODUCTION OF CHROMANOL DERIVATIVE | BASF AG | 2000-04-04 | — | — | JP | disclosed |
| EP-0989126-A1 | Process for the production of chromanol derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-29 | — | — | EP | disclosed |
| US-4968819-A | CATALYTIC SELECTIVE ETHERIFICATION | ALKALOIDA VEGYESZETI GYAR (HU) | 1990-11-06 | — | — | US | disclosed |
| US-4882353-A | ANTICOAGULANTS, VASODILATION, AND BRONCHODILATOR AGENT | BAYER AKTIENGESELLSCHAFT (DE) | 1989-11-21 | — | — | US | disclosed |
| US-4866089-A | 7-ALKOXY-8-METHOXY-2,2-DIMETHYL-2H-CHROMENES; INSECTICIDES, NEMATOCIDES | ALKALOIDA VEGYESZETI GYAR (HU) | 1989-09-12 | — | — | US | disclosed |
| EP-0315009-A2 | Chroman derivatives, process for their preparation and their use in medicines | BAYER AG (DE) | 1989-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | STING1, IRF3, CGAS | MAOB 730/4885ADORA3 591/4885AR 3325/4885 |
| US-20220402898-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | STING1, IRF3, CGAS | MAOB 730/4885ADORA3 591/4885AR 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.